BRAF and melanoma: Although previous findings based on the differential gene expression analysis of BRAFV600E and BRAFWT samples provided novel insights into the understanding of BRAF-driven biology in melanoma [14,15], applying a sensitive detection method towards the functional consequences of the driver mutation BRAFV600E from a cohort of clinical samples is challenging.